Your session is about to expire
← Back to Search
CGM for Type 2 Diabetes Risk Evaluation
Study Summary
This trial will compare the results of a Continuous Glucose Monitor to the standard 2-hour Oral Glucose Tolerance Test in order to see if the CGM is a safe, effective, and acceptable way to evaluate type 2 diabetes risk in youth.
- Insulin Resistance
- Prediabetes
- Obesity
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently taking hydroxyurea, which can affect continuous glucose monitoring (CGM).You have serious problems with thinking and memory.You are currently pregnant or have been pregnant in the past.You have started puberty and are at least at stage 2 of physical development.You are very overweight for your age and gender, or your body mass index (BMI) is higher than a certain number.You have used medication for diabetes in the past month.You have type 1 diabetes, cystic fibrosis-related diabetes, or diabetes caused by certain medications.A) You are at a higher risk for type 2 diabetes due to your race/ethnicity, or you have certain health conditions or family history. B) Your recent blood sugar levels are in a range that indicates a risk for type 2 diabetes.
- Group 1: CGM use for T2D risk evaluation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals have enrolled in this clinical research?
"Yes, the evidence on clinicaltrials.gov confirms that this investigation is presently looking for participants. This trial was first launched on October 11th 2022 and has since been updated as of October 18th 2022; it requires 40 individuals to enroll from 1 medical centre."
Are you currently accepting volunteers for this clinical trial?
"Affirmative. Clinicaltrials.gov reveals that this research is actively seeking volunteers; it was initially posted on October 11th 2022 and the details were most recently updated on the 18th of said month. The program requires 40 participants to be gathered from one medical site in total."
What criteria must be met for an individual to qualify for participation in this research?
"This ongoing clinical trial is seeking 40 participants aged between 8 and 18 who display signs of insulin resistance. All recruits must fulfil the following criteria: gender-neutral, Tanner 2 or higher pubertal development, overweight/obese (BMI≥85th percentile for age and sex OR ≥ 25kg/m2 in those over 18 years), within 6 months have had abnormal HbA1c levels, fasting glucose scores >100mg/dL, OGTT plasma glucose scores above 140 mg/DL; they also need to belong to one of the specified races - Black, Hispanic Asian Native American Pacific Islander - have dyslip"
Does this trial accept applicants aged under 50?
"As established by the inclusion criteria, eligible participants for this medical trial must be between 8 and 18 years old. In total, there are 80 studies pertaining to those under 18 while 352 studies have been conducted on people over 65."
Share this study with friends
Copy Link
Messenger